Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
357
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
+651K
-
Total reported value, excl. options
-
$6.99B
-
Value change
-
+$119M
-
Put/Call ratio
-
2.15
-
Number of buys
-
164
-
Number of sells
-
-167
-
Price
-
$189.62
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2020
409 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2020.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 357 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 152M outstanding shares and own 24.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.7M shares), VANGUARD GROUP INC (3.64M shares), WELLINGTON MANAGEMENT GROUP LLP (1.57M shares), BROWN CAPITAL MANAGEMENT LLC (1.56M shares), BAMCO INC /NY/ (1.53M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.36M shares), Neuberger Berman Group LLC (1.35M shares), Champlain Investment Partners, LLC (1.1M shares), MAIRS & POWER INC (1.02M shares), and Jackson Square Partners, LLC (995K shares).
This table shows the top 357 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.